WA High Risk Medication Policy - No Longer Applicable - Superseded by MP 0131/20 - 10 February 2020

Applicable to:

Description: The purpose of the WA High Risk Medication Policy (the policy) is to improve patient safety by raising awareness amongst all clinical staff that prescribe, dispense or administer high-risk medications to establish locally-based safeguards and strategies to reduce the risk of errors with these medicines during all phases of the medication use process.

WA High Risk Medication Policy

Background

The purpose of the WA High Risk Medication Policy (the policy) is to improve patient safety by raising awareness amongst all clinical staff that prescribe, dispense or administer high-risk medications.

The policy is based on the National Safety and Quality Health Service Standard action 4.11 developed by the Australian Commission on Safety and Quality in Health Care (ACSQHC).

Hospitals and health services must determine which medications are deemed high risk within their patient population and clinical settings in accordance with the National Safety and Quality Health Service Standard 4.11.

At a minimum the following medications, recommended by ACSQHC should be considered for inclusion in the high risk medication register.

•           A         Antimicrobials

•           P         Potassium and other electrolytes, Psychotropic medications

•           I           Insulin           

•           N         Narcotics / Opioids

•           C         Chemotherapeutic agents

•           H         Heparin and other anticoagulants           

•           S         Systems (e.g. safe administration of liquid medications)

Governance arrangements for medication management and medication safety should include maintaining a list of identified high risk medications for the hospital, and assignment of responsibility to the tasks of risk assessment, management, and monitoring the use of high risk medicines.

The purpose of identifying high risk medications is to establish locally-based safeguards and strategies to reduce the risk of errors with these medicines during all phases of the medication use process.


Professor Bryant Stokes
A/DIRECTOR GENERAL
DEPARTMENT OF HEALTH WA

Date of effect: 31 August 2014 to 10 February 2020

Policy Framework

Related documents